Search Results

You are looking at 81 - 90 of 176 items for :

  • "radioactive iodine" x
Clear All
Tetsuya Mizokami Tajiri Thyroid Clinic, Kumamoto, Japan

Search for other papers by Tetsuya Mizokami in
Google Scholar
PubMed
Close
,
Katsuhiko Hamada Tajiri Thyroid Clinic, Kumamoto, Japan

Search for other papers by Katsuhiko Hamada in
Google Scholar
PubMed
Close
,
Tetsushi Maruta Tajiri Thyroid Clinic, Kumamoto, Japan

Search for other papers by Tetsushi Maruta in
Google Scholar
PubMed
Close
,
Kiichiro Higashi Tajiri Thyroid Clinic, Kumamoto, Japan

Search for other papers by Kiichiro Higashi in
Google Scholar
PubMed
Close
, and
Junichi Tajiri Tajiri Thyroid Clinic, Kumamoto, Japan

Search for other papers by Junichi Tajiri in
Google Scholar
PubMed
Close

radioactive iodine therapy in adolescent patients with Graves' disease. Int J Pediatr Endocrinol 2011;2011:14. 10.1186/1687-9856-2011-14 22060749 6 Tajiri J: Radioactive iodine therapy for goitrous Hashimoto's thyroiditis. J Clin Endocrinol Metab 2006

Free access
Aamna Hassan Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan

Search for other papers by Aamna Hassan in
Google Scholar
PubMed
Close
,
Saima Riaz Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan

Search for other papers by Saima Riaz in
Google Scholar
PubMed
Close
,
Humayun Bashir Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan

Search for other papers by Humayun Bashir in
Google Scholar
PubMed
Close
,
M. Khalid Nawaz Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan

Search for other papers by M. Khalid Nawaz in
Google Scholar
PubMed
Close
, and
Raza Hussain Departments of Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan

Search for other papers by Raza Hussain in
Google Scholar
PubMed
Close

recurrence classification at baseline [ 1 ] and response to initial therapy 6-24 months after radioactive iodine (RAI) ablation [ 2 ], the more aggressive subset of patients should theoretically be identified in whom the chance of developing radioiodine

Free access
Shinsuke Shinkai Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Shinsuke Shinkai in
Google Scholar
PubMed
Close
,
Kenji Ohba Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan
Medical Education Center, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Kenji Ohba in
Google Scholar
PubMed
Close
,
Kennichi Kakudo Department of Pathology and Thyroid Disease Center, Izumi City General Hospital, Osaka, Japan

Search for other papers by Kennichi Kakudo in
Google Scholar
PubMed
Close
,
Takayuki Iwaki Department of Pharmacology, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Takayuki Iwaki in
Google Scholar
PubMed
Close
,
Yoshihiro Mimura Department of Internal Medicine, American Hospital of Paris, Neuilly sur Seine, France

Search for other papers by Yoshihiro Mimura in
Google Scholar
PubMed
Close
,
Akio Matsushita Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Akio Matsushita in
Google Scholar
PubMed
Close
,
Go Kuroda Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Go Kuroda in
Google Scholar
PubMed
Close
,
Yuki Sakai Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Yuki Sakai in
Google Scholar
PubMed
Close
,
Nobuhiko Nishino Department of Surgery, Maruyama Hospital, Shizuoka, Japan

Search for other papers by Nobuhiko Nishino in
Google Scholar
PubMed
Close
,
Kazuo Umemura Medical Education Center, Hamamatsu University School of Medicine, Shizuoka, Japan
Department of Pharmacology, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Kazuo Umemura in
Google Scholar
PubMed
Close
,
Takafumi Suda Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Takafumi Suda in
Google Scholar
PubMed
Close
, and
Shigekazu Sasaki Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Shigekazu Sasaki in
Google Scholar
PubMed
Close

for Treatment of Thyroid Tumor [ 5 ]. First, we initiated TSH-suppressive therapy with levothyroxine after the surgery. Second, he received radioactive iodine ablation. One year after the initial treatment, the patient displayed a serum Tg level of 4

Free access
Ian D Hay Department of Medicine 1, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA

Search for other papers by Ian D Hay in
Google Scholar
PubMed
Close
,
Suneetha Kaggal Department of Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA

Search for other papers by Suneetha Kaggal in
Google Scholar
PubMed
Close
, and
Geoffrey B Thompson Department of Surgery, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA

Search for other papers by Geoffrey B Thompson in
Google Scholar
PubMed
Close

period, negative whole-body scanning (WBS) with radioactive iodine (RAI) and, in later years, non-stimulable TSH responses to thyrotropin-releasing hormone were considered as the ‘gold standards’ for adequate PTC treatment ( 8 , 9 , 10 , 11

Open access
Birgitta Johansson Department of Clinical Neuroscience, Sahlgrenska Academy, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Birgitta Johansson in
Google Scholar
PubMed
Close
,
Mats Holmberg ANOVA, Karolinska University Hospital, Norra Stationsgatan 69, Stockholm, Sweden
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden

Search for other papers by Mats Holmberg in
Google Scholar
PubMed
Close
,
Simon Skau Department of Clinical Neuroscience, Sahlgrenska Academy, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
Department of Pedagogical, Curricular and Professional Studies, Faculty of Education, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Simon Skau in
Google Scholar
PubMed
Close
,
Helge Malmgren Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Helge Malmgren in
Google Scholar
PubMed
Close
, and
Helena Filipsson Nyström Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Helena Filipsson Nyström in
Google Scholar
PubMed
Close

were initially treated with ATD and when necessary with surgery. At 15 months, 36% had undergone thyroidectomy, one patient was treated with radioactive iodine, 47% were receiving ATD, and 17% had no treatment and were in remission. Due to the high

Open access
Jiahui Wu Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Jiahui Wu in
Google Scholar
PubMed
Close
,
Xunyang Hu Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Xunyang Hu in
Google Scholar
PubMed
Close
,
Paula Seal EFW Radiology, Calgary, Alberta, Canada
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Paula Seal in
Google Scholar
PubMed
Close
,
Parthiv Amin Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Parthiv Amin in
Google Scholar
PubMed
Close
,
Brendan Diederichs Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Mayfair Radiology, Calgary, Alberta, Canada

Search for other papers by Brendan Diederichs in
Google Scholar
PubMed
Close
, and
Ralf Paschke Section of Endocrinology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Close

F Yang SP Bulzico DA Corbo R Vaisman M & Tuttle RM . Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine . Journal of Clinical Endocrinology and Metabolism 2016 101 2692 – 2700

Open access
Satoshi Koyama Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan

Search for other papers by Satoshi Koyama in
Google Scholar
PubMed
Close
,
Naritomo Miyake Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan

Search for other papers by Naritomo Miyake in
Google Scholar
PubMed
Close
,
Kazunori Fujiwara Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan

Search for other papers by Kazunori Fujiwara in
Google Scholar
PubMed
Close
,
Tsuyoshi Morisaki Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan

Search for other papers by Tsuyoshi Morisaki in
Google Scholar
PubMed
Close
,
Takahiro Fukuhara Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan

Search for other papers by Takahiro Fukuhara in
Google Scholar
PubMed
Close
,
Hiroya Kitano Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan
Center for Head and Neck Surgery, Kusatsu General Hospital, Kusatsu, Japan

Search for other papers by Hiroya Kitano in
Google Scholar
PubMed
Close
, and
Hiromi Takeuchi Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan

Search for other papers by Hiromi Takeuchi in
Google Scholar
PubMed
Close

received no treatment prior to lenvatinib; the remaining patient (case 2) had undergone total thyroidectomy and radioactive iodine treatment prior to receiving lenvatinib. The 4 patients except case 1 were diagnosed with unilateral recurrent laryngeal nerve

Free access
Anne-Sophie Bertrand Department of Interventional Radiology Imaging, Antoine Lacassagne Cancer Research Center, Nice, France

Search for other papers by Anne-Sophie Bertrand in
Google Scholar
PubMed
Close
,
Antoine Iannessi Department of Interventional Radiology Imaging, Antoine Lacassagne Cancer Research Center, Nice, France

Search for other papers by Antoine Iannessi in
Google Scholar
PubMed
Close
,
Isabelle Peyrottes Department of Anatomopathology, Antoine Lacassagne Cancer Research Center, Nice, France

Search for other papers by Isabelle Peyrottes in
Google Scholar
PubMed
Close
,
Alexis Lacout Department of Radiology, Centre médico-chirurgical ELSAN, Aurillac, France

Search for other papers by Alexis Lacout in
Google Scholar
PubMed
Close
,
Antoine Thyss Department of Oncology, Antoine Lacassagne Cancer Research Center, Nice, France

Search for other papers by Antoine Thyss in
Google Scholar
PubMed
Close
, and
Pierre-Yves Marcy Department of Interventional Radiology and Diagnostic Imaging, Polyclinique Les Fleurs Groupe ELSAN, Ollioules, France

Search for other papers by Pierre-Yves Marcy in
Google Scholar
PubMed
Close

to be published: all authors. References 1 Rosario PW , Mourão GF , Calsolari MR . Efficacy of adjuvant therapy with 3.7 GBq radioactive iodine in intermediate-risk patients with ‘higher risk features’ and predictive value

Free access
Laura Moss Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, United Kingdom

Search for other papers by Laura Moss in
Google Scholar
PubMed
Close
,
Catrin Cox Centre for Trials Research, Cardiff University, Cardiff, United Kingdom

Search for other papers by Catrin Cox in
Google Scholar
PubMed
Close
,
Jonathan Wadsley Weston Park Cancer Centre, Sheffield, United Kingdom

Search for other papers by Jonathan Wadsley in
Google Scholar
PubMed
Close
,
Kate Newbold The Royal Marsden NHS Foundation Trust, London, United Kingdom

Search for other papers by Kate Newbold in
Google Scholar
PubMed
Close
,
Mark W.J. Strachan Western General Hospital, Edinburgh, United Kingdom

Search for other papers by Mark W.J. Strachan in
Google Scholar
PubMed
Close
,
Maralyn Druce Barts and the London School of Medicine and Dentistry, London, United Kingdom

Search for other papers by Maralyn Druce in
Google Scholar
PubMed
Close
,
Neil Tolley Imperial College Healthcare NHS Trust, London, United Kingdom

Search for other papers by Neil Tolley in
Google Scholar
PubMed
Close
,
Kathryn Graham Beatson Oncology Centre, Glasgow, United Kingdom

Search for other papers by Kathryn Graham in
Google Scholar
PubMed
Close
,
Sarah Jefferies Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

Search for other papers by Sarah Jefferies in
Google Scholar
PubMed
Close
,
Lydia Fresco University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom

Search for other papers by Lydia Fresco in
Google Scholar
PubMed
Close
,
Suganya Sivabalasingham University College Hospital NHS Foundation Trust, London, United Kingdom

Search for other papers by Suganya Sivabalasingham in
Google Scholar
PubMed
Close
,
Alistair Balfour East Kent Hospitals University NHS Foundation Trust, Canterbury, United Kingdom

Search for other papers by Alistair Balfour in
Google Scholar
PubMed
Close
, and
Chris Hurt Centre for Trials Research, Cardiff University, Cardiff, United Kingdom

Search for other papers by Chris Hurt in
Google Scholar
PubMed
Close

assess thyroid cancer issues and EORTC QLQ-GINET21 [ 7 ] which assesses issues relevant to neuroendocrine tumours. The City of Hope Scale was amended by removing four questions related to radioactive iodine treatment which is not relevant to the study

Free access
Mafalda Marcelino Department of Endocrinology, Armed Forces University Hospital, Lisbon, Portugal
Department of Endocrinology, Portuguese Institute of Oncology, Lisbon, Portugal

Search for other papers by Mafalda Marcelino in
Google Scholar
PubMed
Close
,
Pedro Marques Department of Endocrinology, Portuguese Institute of Oncology, Lisbon, Portugal

Search for other papers by Pedro Marques in
Google Scholar
PubMed
Close
,
Luis Lopes Department of Endocrinology, Armed Forces University Hospital, Lisbon, Portugal

Search for other papers by Luis Lopes in
Google Scholar
PubMed
Close
,
Valeriano Leite Department of Endocrinology, Portuguese Institute of Oncology, Lisbon, Portugal

Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Close
, and
João Jácome de Castro Department of Endocrinology, Armed Forces University Hospital, Lisbon, Portugal

Search for other papers by João Jácome de Castro in
Google Scholar
PubMed
Close

. Endocr J 2005;52:309-316. 10.1507/endocrj.52.309 16006725 3 Uludag M, Yetkin G, Citgez B, Isgor A, Basak T: Autonomously functioning thyroid nodule treated with radioactive iodine and later diagnosed as papillary thyroid cancer. Hormones 2008

Free access